Environmental Impact Assessment Study Report for Insulin and Vaccines Manufacturing Factory

Environmental Impact Assessment  Study Report for Insulin and Vaccines Manufacturing Factory

 

PROJECT INFO

Project start: 2016

Project Completion: 2016

CLIENT INFO

Client: Q - Pharma

SERVICES PROVIDED

Environmental  

PROJECT DETAILS

Al Sulaiti Holding is one of Qatar’s leading private companies that has played a significant role in the development of the Qatar economy and infrastructure by attracting foreign investments and creating immense career opportunities. Established in the 1990’s, Al Sulaiti Holdings was able to keep pace with the prosperity and growth of Qatar to develop and nourish its business opportunities.

The founder of Al Sulaiti Holdings is Dr. Ahmed Bin Mohammad Al Haie Al Sulaiti, a Qatari businessman, a well-known visionary entrepreneur in the region that has achieved success building a diverse business portfolio that is known on the local, regional and international level.

Al Sulaiti Holdings has various divisions operating under its umbrella; Pharmaceuticals, Celebration Hall, Construction, Real Estate, Transport and a Law Firm. 

The proposed Q-Pharma facility would include formulations of insulin and vaccines. The facility would be facilitated with latest technological machineries available in the market.

The project scope comprises of carrying out Environmental Impact Assessment for this facility. Q-Pharma had approached Qatar Design Consortium to carry out the scope of work (SoW) and Environmental Impact Assessment (EIA) study and to prepare the report submitted to the MME and to obtain Environmental Approval from MME. A structured and detailed survey including walk over survey, sampling analysis were performed which includes critical environmental components like ambient air quality, ground water, soil and noise within study area.